Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release

Raffaella Melzi, Lorenzo Piemonti, Rita Nano, Barbara Clissi, Giliola Calori, Barbara Antonioli, Simona Marzorati, Gianluca Perseghin, Valeria Di Carlo, Federico Bertuzzi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Human islets have chemotactic activity toward macrophages mediated by the secretion of monocyte chemoattractant protein-1 (CCL2/MCP-1) that negatively affect clinical outcome in islet after kidney recipients. The aim of the present work was to identify the donor features and the variables involved in the procedures of islet isolation associated with islet CCL2/MCP-1 release in vitro. We used a retrospective approach studying the outcome in 170 islet isolations. The univariate analysis demonstrated that CCL2/MCP-1 release was significantly associated with the surgical team in charge for organ harvesting, the proteins for dilution solution, the type of gradient, the type of enzyme, and the donor noradrenalin treatment. The multivariate analysis confirmed that the surgical team (P=0.001) and the enzyme (P=0.001) were independently associated with in vitro CCL2/MCP-1 islet release (r2= 17%). Strategies aimed to optimize the procedures of organ harvesting and islet isolation may reduce the pro-inflammatory properties of the preparation and therefore may improve islet engraftment.

Original languageEnglish
Pages (from-to)1564-1567
Number of pages4
JournalTransplantation
Volume78
Issue number10
DOIs
Publication statusPublished - Nov 27 2004

Fingerprint

Tissue and Organ Harvesting
Chemokine CCL2
Enzymes
Norepinephrine
Multivariate Analysis
Macrophages
Kidney
Proteins
human CCL2 protein
In Vitro Techniques

Keywords

  • CCL2/MCP-1
  • Collagenase
  • Islet allotransplantation
  • Islet isolation
  • Pancreas donor
  • Purification

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release. / Melzi, Raffaella; Piemonti, Lorenzo; Nano, Rita; Clissi, Barbara; Calori, Giliola; Antonioli, Barbara; Marzorati, Simona; Perseghin, Gianluca; Di Carlo, Valeria; Bertuzzi, Federico.

In: Transplantation, Vol. 78, No. 10, 27.11.2004, p. 1564-1567.

Research output: Contribution to journalArticle

Melzi, R, Piemonti, L, Nano, R, Clissi, B, Calori, G, Antonioli, B, Marzorati, S, Perseghin, G, Di Carlo, V & Bertuzzi, F 2004, 'Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release', Transplantation, vol. 78, no. 10, pp. 1564-1567. https://doi.org/10.1097/01.TP.0000144184.20085.41
Melzi, Raffaella ; Piemonti, Lorenzo ; Nano, Rita ; Clissi, Barbara ; Calori, Giliola ; Antonioli, Barbara ; Marzorati, Simona ; Perseghin, Gianluca ; Di Carlo, Valeria ; Bertuzzi, Federico. / Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release. In: Transplantation. 2004 ; Vol. 78, No. 10. pp. 1564-1567.
@article{4ece0b471f394e55b4d183e9f85d3e46,
title = "Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release",
abstract = "Human islets have chemotactic activity toward macrophages mediated by the secretion of monocyte chemoattractant protein-1 (CCL2/MCP-1) that negatively affect clinical outcome in islet after kidney recipients. The aim of the present work was to identify the donor features and the variables involved in the procedures of islet isolation associated with islet CCL2/MCP-1 release in vitro. We used a retrospective approach studying the outcome in 170 islet isolations. The univariate analysis demonstrated that CCL2/MCP-1 release was significantly associated with the surgical team in charge for organ harvesting, the proteins for dilution solution, the type of gradient, the type of enzyme, and the donor noradrenalin treatment. The multivariate analysis confirmed that the surgical team (P=0.001) and the enzyme (P=0.001) were independently associated with in vitro CCL2/MCP-1 islet release (r2= 17{\%}). Strategies aimed to optimize the procedures of organ harvesting and islet isolation may reduce the pro-inflammatory properties of the preparation and therefore may improve islet engraftment.",
keywords = "CCL2/MCP-1, Collagenase, Islet allotransplantation, Islet isolation, Pancreas donor, Purification",
author = "Raffaella Melzi and Lorenzo Piemonti and Rita Nano and Barbara Clissi and Giliola Calori and Barbara Antonioli and Simona Marzorati and Gianluca Perseghin and {Di Carlo}, Valeria and Federico Bertuzzi",
year = "2004",
month = "11",
day = "27",
doi = "10.1097/01.TP.0000144184.20085.41",
language = "English",
volume = "78",
pages = "1564--1567",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release

AU - Melzi, Raffaella

AU - Piemonti, Lorenzo

AU - Nano, Rita

AU - Clissi, Barbara

AU - Calori, Giliola

AU - Antonioli, Barbara

AU - Marzorati, Simona

AU - Perseghin, Gianluca

AU - Di Carlo, Valeria

AU - Bertuzzi, Federico

PY - 2004/11/27

Y1 - 2004/11/27

N2 - Human islets have chemotactic activity toward macrophages mediated by the secretion of monocyte chemoattractant protein-1 (CCL2/MCP-1) that negatively affect clinical outcome in islet after kidney recipients. The aim of the present work was to identify the donor features and the variables involved in the procedures of islet isolation associated with islet CCL2/MCP-1 release in vitro. We used a retrospective approach studying the outcome in 170 islet isolations. The univariate analysis demonstrated that CCL2/MCP-1 release was significantly associated with the surgical team in charge for organ harvesting, the proteins for dilution solution, the type of gradient, the type of enzyme, and the donor noradrenalin treatment. The multivariate analysis confirmed that the surgical team (P=0.001) and the enzyme (P=0.001) were independently associated with in vitro CCL2/MCP-1 islet release (r2= 17%). Strategies aimed to optimize the procedures of organ harvesting and islet isolation may reduce the pro-inflammatory properties of the preparation and therefore may improve islet engraftment.

AB - Human islets have chemotactic activity toward macrophages mediated by the secretion of monocyte chemoattractant protein-1 (CCL2/MCP-1) that negatively affect clinical outcome in islet after kidney recipients. The aim of the present work was to identify the donor features and the variables involved in the procedures of islet isolation associated with islet CCL2/MCP-1 release in vitro. We used a retrospective approach studying the outcome in 170 islet isolations. The univariate analysis demonstrated that CCL2/MCP-1 release was significantly associated with the surgical team in charge for organ harvesting, the proteins for dilution solution, the type of gradient, the type of enzyme, and the donor noradrenalin treatment. The multivariate analysis confirmed that the surgical team (P=0.001) and the enzyme (P=0.001) were independently associated with in vitro CCL2/MCP-1 islet release (r2= 17%). Strategies aimed to optimize the procedures of organ harvesting and islet isolation may reduce the pro-inflammatory properties of the preparation and therefore may improve islet engraftment.

KW - CCL2/MCP-1

KW - Collagenase

KW - Islet allotransplantation

KW - Islet isolation

KW - Pancreas donor

KW - Purification

UR - http://www.scopus.com/inward/record.url?scp=9244264389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9244264389&partnerID=8YFLogxK

U2 - 10.1097/01.TP.0000144184.20085.41

DO - 10.1097/01.TP.0000144184.20085.41

M3 - Article

C2 - 15599324

AN - SCOPUS:9244264389

VL - 78

SP - 1564

EP - 1567

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 10

ER -